1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Carcinoma, Anaplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Areces, L; Bussolati, G; Cassoni, P; Chini, B; Chinol, M; Manning, M; Marrocco, T; Paganelli, G; Papi, S; Reversi, A | 1 |
Axworthy, DB; Beaumier, PL; Fritzberg, AR; Gustavson, LM; Hobson, LJ; Hylarides, MD; Mallett, RW; Reno, JM; Su, F; Theodore, LJ | 1 |
2 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Carcinoma, Anaplastic
Article | Year |
---|---|
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.
Topics: Animals; Breast Neoplasms; Carcinoma; Chelating Agents; COS Cells; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Neoplasms; Oxytocin; Protein Binding; Radioactive Tracers; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Oxytocin; Sensitivity and Specificity; Stomach Neoplasms; Tissue Distribution; Transfection; Tumor Cells, Cultured; Vasotocin | 2003 |
Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Adhesion Molecules; Chelating Agents; Colonic Neoplasms; Epithelial Cell Adhesion Molecule; Heterocyclic Compounds, 1-Ring; Humans; Mice; Mice, Nude; Molecular Structure; Neoplasm Transplantation; Radioimmunotherapy; Radiopharmaceuticals; Transplantation, Heterologous; Yttrium Radioisotopes | 2000 |